Open offer by Harmony Remedies for 40% of N2N Technologies at ₹4.30/share closed with zero equity shares tendered by public shareholders.
Post-offer advertisement published on May 19, 2026, in Financial Express, Jansatta, Tarun Bharat, and Navshakti newspapers as regulatory compliance.
Himalaya Nutravedics filed DRHP for IPO of 25 lakh shares on BSE SME platform, inviting public comments until June 5, 2026.
Puravankara Limited's audited standalone and consolidated financial results for FY26 ending March 31, 2026, approved by board on May 18, 2026.